Trial intelligence / Profile preview

NEOSURF: Calfactant vs Poractant in Preterm RDS

NCT02834624Completed

Sponsor
University of Missouri
Start
Jul 2013
Primary completion
Feb 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of calfactant in respiratory distress syndrome (RDS) (2 arms), sponsored by University of Missouri. Primary endpoint: Change From Baseline in Blood C-reactive Protein at 48 hours. Started Jul 2013; status: completed.

02

Drugs

calfactant
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NCT02834624.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02834624.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call